Clinical Trials Browser

Phase 1/2 × Melanoma × ADI PEG20 × Clear all

NCT00520299 2022-10-25

Study of ADI-PEG 20 in Patients With Advanced Melanoma

Phase 1/2 Completed

31 enrolled 16 charts

Melanoma, Neoplasms, Skin Neoplasms